Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1698
| Despition | GDNF Rat Recombinant |
| SIZE | 2 µg |
| Purity | > 98.0% by HPLC analysis and by SDS-PAGE. |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1634 | NDK E.Coli (AC1634) | 5 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1174 | Synthetic Nanodisc Human CD97 Protein (AC1174) | 10 µg | inquiry |
| ACPP-1639 | Human NGFR Protein (AC1639) | 2 µg | inquiry |
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
| ACPP-1039 | Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) | 50 µg | inquiry |
| ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.